Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 11,469 | 8,790 | 4,284 | 9,066 | 1,498 |
| Cost of Goods | 1,421 | 1,028 | 497 | 378 | 230 |
| Gross Profit | 10,048 | 7,762 | 3,787 | 8,688 | 1,268 |
| Operating Expenses | 63,000 | 49,893 | 43,551 | 54,162 | 54,189 |
| Operating Income | -52,531 | -42,103 | -39,267 | -45,096 | -52,691 |
| Interest Expense | 3,061 | 3,011 | 2,144 | 46 | 0 |
| Other Income | 3,413 | 2,621 | 550 | 141 | -73 |
| Pre-tax Income | -52,179 | -42,493 | -40,861 | -45,001 | -52,764 |
| Net Income Continuous | -52,179 | -42,493 | -40,861 | -45,001 | -52,764 |
| Net Income | $-52,179 | $-42,493 | $-40,861 | $-45,001 | $-52,764 |
| EPS Basic Total Ops | -0.92 | -0.74 | -0.79 | -0.89 | -1.05 |
| EPS Basic Continuous Ops | -0.92 | -0.74 | -0.79 | -0.89 | -1.05 |
| EPS Diluted Total Ops | -0.92 | -0.74 | -0.79 | -0.89 | -1.05 |
| EPS Diluted Continuous Ops | -0.92 | -0.74 | -0.79 | -0.89 | -1.05 |
| EBITDA(a) | $-49,013 | $-43,851 | $-36,635 | $-44,658 | $-52,341 |